PubMed:15897593 JSONTXT 23 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue #label ID:
T1 0-11 ChemicalEntity denotes Dexrazoxane http://purl.obolibrary.org/obo/CHEBI_50223|D064730
T25709 29-45 DiseaseOrPhenotypicFeature denotes myelosuppression DISEASE
T3 84-93 ChemicalEntity denotes etoposide http://purl.obolibrary.org/obo/CHEBI_4911|D005047
T5 98-110 ChemicalEntity denotes daunorubicin http://purl.obolibrary.org/obo/CHEBI_41977|http://purl.obolibrary.org/obo/CHEBI_64677|D003630
T8 119-130 ChemicalEntity denotes doxorubicin http://purl.obolibrary.org/obo/CHEBI_28748|http://purl.obolibrary.org/obo/CHEBI_64816|D004317
T11 145-159 ChemicalEntity denotes anthracyclines http://purl.obolibrary.org/obo/CHEBI_48120|http://purl.obolibrary.org/obo/CHEBI_49322|D018943
T14 160-172 ChemicalEntity denotes daunorubicin http://purl.obolibrary.org/obo/CHEBI_41977|http://purl.obolibrary.org/obo/CHEBI_64677|D003630
T17 177-188 ChemicalEntity denotes doxorubicin http://purl.obolibrary.org/obo/CHEBI_28748|http://purl.obolibrary.org/obo/CHEBI_64816|D004317
T20 197-215 ChemicalEntity denotes epipodophyllotoxin ChemicalEntity|D011034
T22 216-225 ChemicalEntity denotes etoposide http://purl.obolibrary.org/obo/CHEBI_4911|D005047
T2 318-334 DiseaseOrPhenotypicFeature denotes myelosuppression DISEASE
T59842 339-355 DiseaseOrPhenotypicFeature denotes cardiac toxicity D066126
T24 373-384 ChemicalEntity denotes Dexrazoxane http://purl.obolibrary.org/obo/CHEBI_50223|D064730
T99111 386-390 GeneOrGeneProduct denotes ICRF
T26 386-394 ChemicalEntity denotes ICRF-187 ChemicalEntity|D064730
T28 434-447 ChemicalEntity denotes anthracycline http://purl.obolibrary.org/obo/CHEBI_48120|D018943
T4 456-470 DiseaseOrPhenotypicFeature denotes cardiotoxicity D066126
T24848 530-550 DiseaseOrPhenotypicFeature denotes hematologic toxicity DISEASE
T30 581-592 ChemicalEntity denotes dexrazoxane http://purl.obolibrary.org/obo/CHEBI_50223|D064730
T8704 688-693 OrganismTaxon denotes human
T77850 698-704 OrganismTaxon denotes murine
T32 731-740 ChemicalEntity denotes etoposide http://purl.obolibrary.org/obo/CHEBI_4911|D005047
T34 742-754 ChemicalEntity denotes daunorubicin http://purl.obolibrary.org/obo/CHEBI_41977|http://purl.obolibrary.org/obo/CHEBI_64677|D003630
T37 760-771 ChemicalEntity denotes doxorubicin http://purl.obolibrary.org/obo/CHEBI_28748|http://purl.obolibrary.org/obo/CHEBI_64816|D004317
T40 776-787 ChemicalEntity denotes dexrazoxane http://purl.obolibrary.org/obo/CHEBI_50223|D064730
T37556 878-882 OrganismTaxon denotes mice
T42 901-910 ChemicalEntity denotes etoposide http://purl.obolibrary.org/obo/CHEBI_4911|D005047
T44 912-924 ChemicalEntity denotes daunorubicin http://purl.obolibrary.org/obo/CHEBI_41977|http://purl.obolibrary.org/obo/CHEBI_64677|D003630
T47 930-941 ChemicalEntity denotes doxorubicin http://purl.obolibrary.org/obo/CHEBI_28748|http://purl.obolibrary.org/obo/CHEBI_64816|D004317
T50 959-970 ChemicalEntity denotes dexrazoxane http://purl.obolibrary.org/obo/CHEBI_50223|D064730
T52 1081-1092 ChemicalEntity denotes dexrazoxane http://purl.obolibrary.org/obo/CHEBI_50223|D064730
T6 1101-1117 DiseaseOrPhenotypicFeature denotes myelosuppression DISEASE
T7 1122-1133 DiseaseOrPhenotypicFeature denotes weight loss D015431
T54 1139-1151 ChemicalEntity denotes daunorubicin http://purl.obolibrary.org/obo/CHEBI_41977|http://purl.obolibrary.org/obo/CHEBI_64677|D003630
T57 1156-1165 ChemicalEntity denotes etoposide http://purl.obolibrary.org/obo/CHEBI_4911|D005047
T50359 1169-1173 OrganismTaxon denotes mice
T59 1252-1263 ChemicalEntity denotes dexrazoxane http://purl.obolibrary.org/obo/CHEBI_50223|D064730
T13772 1280-1296 DiseaseOrPhenotypicFeature denotes myelosuppression DISEASE
T9 1298-1309 DiseaseOrPhenotypicFeature denotes weight loss D015431
T10 1328-1340 DiseaseOrPhenotypicFeature denotes cytotoxicity DISEASE
T61 1346-1357 ChemicalEntity denotes doxorubicin http://purl.obolibrary.org/obo/CHEBI_28748|http://purl.obolibrary.org/obo/CHEBI_64816|D004317
T64 1422-1433 ChemicalEntity denotes dexrazoxane http://purl.obolibrary.org/obo/CHEBI_50223|D064730
T66 1499-1510 ChemicalEntity denotes doxorubicin http://purl.obolibrary.org/obo/CHEBI_28748|http://purl.obolibrary.org/obo/CHEBI_64816|D004317
T69 1548-1560 ChemicalEntity denotes daunorubicin http://purl.obolibrary.org/obo/CHEBI_41977|http://purl.obolibrary.org/obo/CHEBI_64677|D003630
T72 1718-1727 ChemicalEntity denotes etoposide http://purl.obolibrary.org/obo/CHEBI_4911|D005047
T74 1778-1789 ChemicalEntity denotes dexrazoxane http://purl.obolibrary.org/obo/CHEBI_50223|D064730
T83458 1810-1818 OrganismTaxon denotes patients
T55937 1824-1840 DiseaseOrPhenotypicFeature denotes brain metastases D001932
T76 1851-1862 ChemicalEntity denotes dexrazoxane http://purl.obolibrary.org/obo/CHEBI_50223|D064730
T78 1881-1890 ChemicalEntity denotes etoposide http://purl.obolibrary.org/obo/CHEBI_4911|D005047
T12 1957-1977 DiseaseOrPhenotypicFeature denotes hematologic toxicity DISEASE
T13 2082-2091 DiseaseOrPhenotypicFeature denotes cytotoxic DISEASE